Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/44866 |
Resumo: | The aim was to analyze the use of cannabidiol as a medicinal treatment for chronic pain by means of an integrative review. This is an Integrative Literature Review (ILR), which set out to identify, synthesize and carry out an extended analysis of the herbal use of cannabidiol. Thirty pieces of literature were selected for full reading and presentation of the results, as they met the objectives. The samples came from 85% of the Medline/PubMed database, in the last five years, with 60% of them using a cross-sectional approach and descriptive nature, and 84% of the patients studied in the studies reported an improvement in the level of chronic and/or neuropathic pain after starting to use Cannabis. In addition to this benefit, others mentioned in the articles were improved sleep and its quality, as well as reduced opioid consumption. With regard to the origin of the pain, half said it was linked to one or more causes, and chronic pain including cancer (nonspecific, intractable and other) was the most mentioned (80%). There is important consensus that medical cannabis can be approved for populations with inflammatory, nociplastic, neuropathic and mixed pain, however, if you are considering using CBD to treat chronic pain or any other MMJ-based condition, it is essential to discuss this with a doctor or healthcare professional to ensure that it is safe and appropriate for your specific situation. In this sense, more studies should be carried out to prove the importance and effectiveness of cannabidiol in the treatment of chronic pain, both from a clinical, review and statistical point of view. |
id |
UNIFEI_89a2c43ff6223d9ffe15c7287afb46e4 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/44866 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Cannabidiol as a phytopharmaceutical for chronic pain: Integrative reviewCannabidiol como fitofármaco para el dolor crónico: Revisión integradoraCanabidiol como fitofármaco da dor crônica: Revisão integrativa PhytodrugsCannabis sativaChronic pain treatmentReview.FitofármacosCannabis sativaTratamiento del dolor crónicoRevisión.FitofármacoCannabis sativaTratamento dor crônicaRevisão.The aim was to analyze the use of cannabidiol as a medicinal treatment for chronic pain by means of an integrative review. This is an Integrative Literature Review (ILR), which set out to identify, synthesize and carry out an extended analysis of the herbal use of cannabidiol. Thirty pieces of literature were selected for full reading and presentation of the results, as they met the objectives. The samples came from 85% of the Medline/PubMed database, in the last five years, with 60% of them using a cross-sectional approach and descriptive nature, and 84% of the patients studied in the studies reported an improvement in the level of chronic and/or neuropathic pain after starting to use Cannabis. In addition to this benefit, others mentioned in the articles were improved sleep and its quality, as well as reduced opioid consumption. With regard to the origin of the pain, half said it was linked to one or more causes, and chronic pain including cancer (nonspecific, intractable and other) was the most mentioned (80%). There is important consensus that medical cannabis can be approved for populations with inflammatory, nociplastic, neuropathic and mixed pain, however, if you are considering using CBD to treat chronic pain or any other MMJ-based condition, it is essential to discuss this with a doctor or healthcare professional to ensure that it is safe and appropriate for your specific situation. In this sense, more studies should be carried out to prove the importance and effectiveness of cannabidiol in the treatment of chronic pain, both from a clinical, review and statistical point of view.El objetivo era analizar el uso del cannabidiol como tratamiento medicinal del dolor crónico mediante una revisión integradora. Se trata de una Revisión Integrativa de la Literatura (RIL), que se propuso identificar, sintetizar y llevar a cabo un análisis ampliado del uso herbal del cannabidiol. Se seleccionaron 30 trabajos para su lectura completa y la presentación de los resultados, ya que cumplían los objetivos. Las muestras procedían en 85% de la base de datos Medline/PubMed, en los últimos cinco años, con 60% de ellas con enfoque transversal y de carácter descriptivo, y el 84% de los pacientes estudiados en los estudios informaron de una mejora en el nivel de dolor crónico y/o neuropático después de comenzar a usar Cannabis. Además de este beneficio, otros mencionados en los artículos fueron la mejora del sueño y de su calidad, así como la reducción del consumo de opioides. En cuanto al origen del dolor, la mitad dijo que estaba relacionado con una o más causas, y dolor crónico, incluido el cáncer (inespecífico, intratable y otros) fue el más mencionado, con un 80%. Existe un importante consenso que el cannabis medicinal puede ser aprobado para personas con dolor inflamatorio, nociplásico, neuropático y mixto, sin embargo, si estás considerando usar CBD para tratar el dolor crónico o cualquier otra condición basada en MMJ, es esencial que lo discutas un médico o profesional de salud para asegurarte de que seguro y apropiado para tu situación específica. Este sentido, deberían realizarse más estudios para demostrar la importancia y eficacia del cannabidiol en el tratamiento del dolor crónico, tanto desde un punto de vista clínico, como de revisión y estadístico.Objetivou analisar o uso do canabidiol como tratamento medicamentoso de dor crônica, por meio de uma revisão integrativa. Trata-se de uma Revisão Integrativa de Literatura (RIL), que se propôs identificar, sintetizar e realizar uma análise ampliada acerca do uso fitoterápico do Canabidiol. Selecionou-se 30 literaturas para leitura integral e apresentação dos resultados, pois, responderam aos objetivos. As amostras foram provenientes em 85% da base Medline/PubMed, nos últimos cinco anos, com 60% destes utilizando método de abordagem transversal e caráter descritivo, e 84% dos pacientes estudados nas pesquisas relataram melhora do nível de dor crônica e/ou neuropática após iniciar o uso de Cannabis. Além desse benefício, outros mencionados nos artigos foram a melhora do sono e da sua qualidade, além da redução do consumo de opioides. No que tange a origem da dor, a literatura afirmou estar ligadas a uma ou mais causas, e a crônica incluindo a cancerígena (inespecífica, intratável e outros) foi a mais mencionada em 80%. Há importante consenso de que a cannabis medicinal pode ser aprovada para população com dor inflamatória, nociplástica, neuropática e mista, entretanto, for considerado o uso do CBD para tratar dor crônica ou qualquer outra condição a base de MMJ, é essencial discutir isso com um médico ou profissional de saúde para garantir que seja seguro e apropriado para a sua situação específica. Nesse sentido, mais estudos devem ser realizados para comprovar a importância e eficácia do canabidiol no tratamento da dor crônica, tanto do ponto de vista clínico, revisão e estatístico.Research, Society and Development2024-01-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4486610.33448/rsd-v13i1.44866Research, Society and Development; Vol. 13 No. 1; e12413144866Research, Society and Development; Vol. 13 Núm. 1; e12413144866Research, Society and Development; v. 13 n. 1; e124131448662525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/44866/35842Copyright (c) 2024 Ademara Guimarães; Camila Araujo; Francisco Soares Neto; Marcella Pimenta Pereira Cruz; Thames Dantas da Silva; Isabela Guerreiro Diniz; Márcia Cristina Monteiro Guimarãeshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessGuimarães, Ademara Araujo, Camila Soares Neto, Francisco Cruz, Marcella Pimenta Pereira Silva, Thames Dantas da Diniz, Isabela Guerreiro Guimarães, Márcia Cristina Monteiro 2024-02-01T09:48:39Zoai:ojs.pkp.sfu.ca:article/44866Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-02-01T09:48:39Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review Cannabidiol como fitofármaco para el dolor crónico: Revisión integradora Canabidiol como fitofármaco da dor crônica: Revisão integrativa |
title |
Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review |
spellingShingle |
Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review Guimarães, Ademara Phytodrugs Cannabis sativa Chronic pain treatment Review. Fitofármacos Cannabis sativa Tratamiento del dolor crónico Revisión. Fitofármaco Cannabis sativa Tratamento dor crônica Revisão. |
title_short |
Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review |
title_full |
Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review |
title_fullStr |
Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review |
title_full_unstemmed |
Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review |
title_sort |
Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review |
author |
Guimarães, Ademara |
author_facet |
Guimarães, Ademara Araujo, Camila Soares Neto, Francisco Cruz, Marcella Pimenta Pereira Silva, Thames Dantas da Diniz, Isabela Guerreiro Guimarães, Márcia Cristina Monteiro |
author_role |
author |
author2 |
Araujo, Camila Soares Neto, Francisco Cruz, Marcella Pimenta Pereira Silva, Thames Dantas da Diniz, Isabela Guerreiro Guimarães, Márcia Cristina Monteiro |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Guimarães, Ademara Araujo, Camila Soares Neto, Francisco Cruz, Marcella Pimenta Pereira Silva, Thames Dantas da Diniz, Isabela Guerreiro Guimarães, Márcia Cristina Monteiro |
dc.subject.por.fl_str_mv |
Phytodrugs Cannabis sativa Chronic pain treatment Review. Fitofármacos Cannabis sativa Tratamiento del dolor crónico Revisión. Fitofármaco Cannabis sativa Tratamento dor crônica Revisão. |
topic |
Phytodrugs Cannabis sativa Chronic pain treatment Review. Fitofármacos Cannabis sativa Tratamiento del dolor crónico Revisión. Fitofármaco Cannabis sativa Tratamento dor crônica Revisão. |
description |
The aim was to analyze the use of cannabidiol as a medicinal treatment for chronic pain by means of an integrative review. This is an Integrative Literature Review (ILR), which set out to identify, synthesize and carry out an extended analysis of the herbal use of cannabidiol. Thirty pieces of literature were selected for full reading and presentation of the results, as they met the objectives. The samples came from 85% of the Medline/PubMed database, in the last five years, with 60% of them using a cross-sectional approach and descriptive nature, and 84% of the patients studied in the studies reported an improvement in the level of chronic and/or neuropathic pain after starting to use Cannabis. In addition to this benefit, others mentioned in the articles were improved sleep and its quality, as well as reduced opioid consumption. With regard to the origin of the pain, half said it was linked to one or more causes, and chronic pain including cancer (nonspecific, intractable and other) was the most mentioned (80%). There is important consensus that medical cannabis can be approved for populations with inflammatory, nociplastic, neuropathic and mixed pain, however, if you are considering using CBD to treat chronic pain or any other MMJ-based condition, it is essential to discuss this with a doctor or healthcare professional to ensure that it is safe and appropriate for your specific situation. In this sense, more studies should be carried out to prove the importance and effectiveness of cannabidiol in the treatment of chronic pain, both from a clinical, review and statistical point of view. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-01-27 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/44866 10.33448/rsd-v13i1.44866 |
url |
https://rsdjournal.org/index.php/rsd/article/view/44866 |
identifier_str_mv |
10.33448/rsd-v13i1.44866 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/44866/35842 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 13 No. 1; e12413144866 Research, Society and Development; Vol. 13 Núm. 1; e12413144866 Research, Society and Development; v. 13 n. 1; e12413144866 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052637356490752 |